MYQORZO™ (aficamten)
| Full Name | MYQORZO™ (aficamten) |
| Drug | aficamten |
| Manufacturer | Cytokinetics, Inc. |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | MYQORZO is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. |
| Disease | Obstructive hypertrophic cardiomyopathy (oHCM) |
| Therapeutic Area | Cardiology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 847-849-1445 |
| Fax Number | 847-892-1127 |
| Product Website | www.myqorzohcp.com |
| REMS Website | www.myqorzorems.com |